Analysis of cytokine and COVID-19 associated cytokine storm researches in scientific literature: A bibliometric study

Havva Hande Keser Şahin; Yılmaz Baş; Engin Şenel

doi:10.5281/zenodo.6501571

Authors

Havva Hande Keser Şahin Hitit University Faculty of Medicine Department of Pathology, Çorum, Turkey https://orcid.org/0000-0003-1827-1039
Yılmaz Baş Hitit University Faculty of Medicine, Department of Pathology, Çorum, Turkey https://orcid.org/0000-0002-4229-8568
Engin Şenel Hitit University Faculty of Medicine, Department of Dermatology and Venereology, Çorum, Turkey https://orcid.org/0000-0001-8098-1686

DOI:

https://doi.org/10.5281/zenodo.6501571

Keywords:

cytokine, cytokine storm, COVID-19, bibliometric, publication trend

Abstract

Objective: We want to present to perform bibliometric analysis of articles on cytokine and cytokine storm published in the academic literature during 1980 to 2018-2020.

Methods: The bibliometric analysis was performed using the Thomson Reuters Web of Science database.

Results: A total of 232,606 articles were retrieved, 82.52% of which were original articles. The United States was the leading country by total publication number (n=84,426, 36.29%), followed by Japan (n=21,983, 9.45%) produced the most literature on cytokine. Among the institutions identified, Harvard University (USA) contributed the most articles on cytokine. All authors and institutions in the top 10 contributor’s lists were from the developed countries.

Conclusion: Researchers from the developing and least developed countries should been courage to perform novel studies on cytokine. Cytokine studies are associated with the pathology and physiological variability of many diseases and may have beneficial results in the medical field. Cytokine and cytokine storm studies may be particularly useful in identifying the pathogenesis of global viral infections such as SARS-CoV-2, evaluating and developing new treatment strategies.

References

Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27-37.

Oppenheim JJ. "Cytokines, their receptors and signals." The autoimmune diseases. Academic Press, 2020; 275-89.

Purasiri P, Mckechnie A, Heys SD, Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology. 1997;92(2):166-72.

Ferreira VL, Borba HHL, Bonetti ADF, Leonart L, Pontarolo R. Cytokines and Interferons: Types and Functions. IntechOpen, 2018.

Hood WW, Wilson CS. "The literature of bibliometrics, scientometrics, and informetrics." Scientometrics 52.2 2001; 291-314.

Şenel E, Demir E. Bibliometric analysis of apitherapy in complementary medicine literature between 1980 and 2016. Complement Ther Clin Pract 2018; 31:47-52.

Şenel E. Evolution of homeopathy: A scientometric analysis of global homeopathyliterature between 1975 and 2017. Complement Ther Clin Pract 2019; 34:165-73.

Zhang H, Zhou P, Wei Y, Yue H, Wang Y, Hu M, et al. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19. Annals of internal medicine 2020;172(9):629-32.

Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003; 200(3):282-9.

Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 2018;104:8-13.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270-3.

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends On ACE2 and TMPRSS 2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020;181(2):271-80.

Hussman JP. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention. Front Pharmacol. 2020 Jul 29;11:1169.

GunnMap. GunnMap 2. http://lert.co.nz/map/. Accessed January 10, 2020. Vosviewer.VOSviewer - Visualizing scientific landscapes. https://www.vosviewer.com/.

Vosviewer, VOSviewer-Visualizing scientificlandscapes. http://www.vosviewer.com/. 2017

Khan YA, Sayed NI, Clagett JA, Korotzer TI, Page RC. Cytokine production in Vitro by lymphoid and non lymphoid cells and partial purification of a bone-resorbing factor. RES J Reticuloendothel Soc 1980; 27(6):547-60.

Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74(4):609-19.

Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006 Sep 7;355(10):1018-28.

Oppenheim JJ. The Future of the Cytokine Discipline. Cold Spring Harb Perspect Biol. 2018 Sep 4;10(9):a028498.

Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: The anger of inflammation. Cytokine. 2020;133:155151

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-4.

Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol 2020;10.1002/jmv.26232.

Ye Q, Wang B, Mao J. The pathogenesis and treatment of the` Cytokine storm' in COVID-19 J Infect. 2020; 80(6):607-13.

Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020; 50(SI-1):620-32.